CDC and FDA Declares Joint Statement in Johnson & Johnson COVID vaccine

The Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) are giving a second thought and declaring a pause on the Johnson & Johnson COVID vaccine this April 2021 for the safety of the people.

COVID19 vaccine is given top priority these days. People worldwide are trying all kinds of immune boosters to help them stay away from viruses. Pharma companies are giving in their best to come out with efficient vaccines and medicines that can help the general public. The governments of all countries worldwide are executing various plans that can help stop the spread of coronavirus.  Right from imposing restrictions to lockdown, the government has put in a lot of effort to curb coronavirus spread.

The authorization of the COVID vaccine 

The Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) have gone ahead and given the green flag to COVID  vaccines for use by the general public worldwide. They have approved COVID vaccines under the Emergency Authorization Use for the betterment of the people. The  Food and Drug Administration (FDA) is working to address the concerns about vaccines among people, to protect and promote the health of the entire population. They are focussing on the strategies that address health disparity.

Side effects of the COVID vaccine are a major concern 

The use of the coronavirus vaccine has brought about a major concern of side effects in immunized people. The major fear of blood clots has been rising among the people about the coronavirus vaccine. This has been noticed in people receiving the Johnson & Johnson (J&J) vaccine which has been administered. The Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) are reviewing data of the six cases reported by the USA  where cases of rare and severe blood clots in the individual have been seen after receiving the  Johnson & Johnson (J&J) vaccine. A type of blood clot called Cerebral Venous Sinus Thrombosis(CVST) was seen in a combination of low platelet count, Thrombocytopenia. 

Details of the six cases detected an under review by The Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA)

All six cases which are under review were seen in the age group between 18 - 48. The symptoms of the blood clot called Cerebral Venous Sinus Thrombosis(CVST) and Thrombocytopenia occurred between 6 - 13 days after vaccination. Administering the COVID vaccine is led to this side effect of blood clots which needs immediate medical attention by The Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA). The general conventional treatment of administering the anticoagulant called heparin is used to treat blood clots may be dangerous. We need to make sure that the vaccine has no interactions with the conventional treatment that is used by the patients. 

FDA ensures efficacy and safety of COVID vaccine 

The Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA)  will convene a meeting of the Advisory Committee on Immunization Practices (ACIP) to further review these six cases of blood clot side effects with COVID vaccine that has come into light this April 2021. FDA will review the analysis and also instigate the cases. Until the process is complete and under review, The Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) are recommending a pause to the use of the vaccine which is the need of the hour. This is a very important announcement by the FDA to ensure that healthcare professionals are aware of the side effects of this vaccine.

Tags : #medicircle #myhealth #FDA #CDC #COVIDvaccine #COVIDvaccinesideeffects

Related Stories

Loading Please wait...


Trending Now

Preparing for the Future: FDA's New COVID-19 Vaccine Recommendation Focuses on KP.2June 17, 2024
From Pap Tests to HPV Screening: A New Era in Cervical Cancer PreventionJune 17, 2024
Rare H9N2 Bird Flu Case Found in Four-Year-Old in India: WHO Highlights Ongoing RisksJune 15, 2024
Kerala Government Announces Aid Package After Kuwait Fire TragedyJune 15, 2024
EV Conference 24---Charging Up for e-mobility Minister Ponnam Prabhakar and Jayesh Ranjan among others to graceJune 14, 2024
Are we on track to end AIDS, end viral hepatitis and end STIs by 2030?June 14, 2024
HR Conclave Focusing on Future-Forward Engineering where Engineering and Management students meet their future employees, thus exposing students to real-world HR challenges and innovative solutionsJune 14, 2024
MAGGI Empowers 10 Women to Bring their Entrepreneurial dreams to lifeJune 13, 2024
FTCCI announced its Annual Excellence Awards and invites entries, last date is 20th June 2024June 13, 2024
Bird Flu Cases by Dr Praveen Gupta, Principle Director and Chief of Neurology, Fortis Hospital.June 13, 2024
Sova Health's $1 Million Seed Funding to Drive Gut Health InnovationJune 13, 2024
The Vital Role of Early Detection: Kevin Jonas on Battling Skin CancerJune 13, 2024
Zumutor Biologics Advances Cancer Care with Novel Immunotherapy ZM008: A First-in-Class Anti LLT1 AntibodyJune 13, 2024
HP Ghosh Hospital Unveils Innovative "Chest Tree" June 12, 2024
Olympus Enhances Innovation Capabilities by Expanding R&D to Hyderabad, IndiaJune 12, 2024
From the frontlines: Homeless person won over alcoholism, survived floods and defeated TBJune 12, 2024
The Role of Hormones in Obesity: Why Men and Women Gain Weight DifferentlyJune 12, 2024
Silent Killer: How a Young Mother’s Vision Loss Led to a Lung Cancer DiagnosisJune 12, 2024
TruAlt Bioenergy’s subsidiary, Leafiniti Bioenergy supplies over 1000 tons of Compressed Biogas to AG&P Pratham in just 5 monthsJune 11, 2024
Southeast Asia's Most Advanced Luxury Postpartum Centre Re'Joy Suites Opens in SingaporeJune 11, 2024